Synonyms: Leustatin® | Litak® | Mavenclad®
cladribine is an approved drug (FDA (1993), EMA (2004))
Compound class:
Synthetic organic
Comment: Cladribine is a purine (adenosine) analogue and an antineoplastic and immunosuppressant agent
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1993), EMA (2004)) |
Approved drug? | Yes. FDA (1993) | EMA (2004) |
IUPAC Name ![]() |
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol |
International Nonproprietary Names ![]() |
|
INN number | INN |
6997 | cladribine |
Synonyms ![]() |
Leustatin® | Litak® | Mavenclad® |
Database Links ![]() |
|
CAS Registry No. | 4291-63-8 |
ChEMBL Ligand | CHEMBL1619 |
DrugBank Ligand | DB00242 |
DrugCentral Ligand | 667 |
GtoPdb PubChem SID | 178101501 |
PubChem CID | 20279 |
RCSB PDB Ligand | CL9 |
Search Google for chemical match using the InChIKey | PTOAARAWEBMLNO-KVQBGUIXSA-N |
Search Google for chemicals with the same backbone | PTOAARAWEBMLNO |
Search PubMed clinical trials | cladribine |
Search PubMed titles | cladribine |
Search PubMed titles/abstracts | cladribine |
UniChem Compound Search for chemical match using the InChIKey | PTOAARAWEBMLNO-KVQBGUIXSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PTOAARAWEBMLNO-KVQBGUIXSA-N |
Wikipedia | Cladribine |